1. Home
  2. OCGN vs BYON Comparison

OCGN vs BYON Comparison

Compare OCGN & BYON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCGN
  • BYON
  • Stock Information
  • Founded
  • OCGN 2013
  • BYON 1997
  • Country
  • OCGN United States
  • BYON United States
  • Employees
  • OCGN N/A
  • BYON N/A
  • Industry
  • OCGN Biotechnology: Biological Products (No Diagnostic Substances)
  • BYON Catalog/Specialty Distribution
  • Sector
  • OCGN Health Care
  • BYON Consumer Discretionary
  • Exchange
  • OCGN Nasdaq
  • BYON Nasdaq
  • Market Cap
  • OCGN 189.6M
  • BYON 173.6M
  • IPO Year
  • OCGN N/A
  • BYON N/A
  • Fundamental
  • Price
  • OCGN $0.67
  • BYON $4.56
  • Analyst Decision
  • OCGN Strong Buy
  • BYON Hold
  • Analyst Count
  • OCGN 3
  • BYON 9
  • Target Price
  • OCGN $6.33
  • BYON $10.67
  • AVG Volume (30 Days)
  • OCGN 3.2M
  • BYON 2.5M
  • Earning Date
  • OCGN 05-09-2025
  • BYON 04-28-2025
  • Dividend Yield
  • OCGN N/A
  • BYON N/A
  • EPS Growth
  • OCGN N/A
  • BYON N/A
  • EPS
  • OCGN N/A
  • BYON N/A
  • Revenue
  • OCGN $4,522,000.00
  • BYON $1,244,431,000.00
  • Revenue This Year
  • OCGN N/A
  • BYON N/A
  • Revenue Next Year
  • OCGN N/A
  • BYON $9.09
  • P/E Ratio
  • OCGN N/A
  • BYON N/A
  • Revenue Growth
  • OCGN N/A
  • BYON N/A
  • 52 Week Low
  • OCGN $0.52
  • BYON $3.54
  • 52 Week High
  • OCGN $2.06
  • BYON $22.39
  • Technical
  • Relative Strength Index (RSI)
  • OCGN 46.49
  • BYON 54.85
  • Support Level
  • OCGN $0.65
  • BYON $3.75
  • Resistance Level
  • OCGN $0.75
  • BYON $4.08
  • Average True Range (ATR)
  • OCGN 0.05
  • BYON 0.30
  • MACD
  • OCGN -0.01
  • BYON 0.11
  • Stochastic Oscillator
  • OCGN 15.38
  • BYON 84.90

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

About BYON Beyond Inc.

Beyond Inc is an online retailer that provides products and services through websites. The company offers a broad range of products, including furniture, décor, area rugs, bedding and bath, home improvement, outdoor, and kitchen and dining items, BMMG (like books, magazines, CDs), electronics, and other items. The home and garden product line accounts for a material part of its total revenue. The company operates through a direct business that makes sales from the company's own inventory, and a partner business that sells merchandise from manufacturers, distributors, and other suppliers through the company's websites. The company generates the majority of its total revenue from partner business in terms of business format, and from the U.S. in terms of market.

Share on Social Networks: